Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: The multinational, prospective, observational TRIAGE study

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Schuetz, Philipp ^a,d   Hausfater, Pierre ^b   Amin, Devendra ^c   Amin, Adina ^c   Haubitz, Sebastian ^a   Faessler, Lukas ^a   Kutz, Alexander ^a   Conca, Antoinette ^a   Reutlinger, Barbara ^a   Canavaggio, Pauline ^b   Sauvin, Gabrielle ^b   Bernard, Maguy ^e   Huber, Andreas ^a   Mueller, Beat ^a,d   Buergi, Ulrich ^a   Tobias, Petra ^a   Grolimund, Eva ^a   Schild, Ursula ^a   Caldara, Zeljka ^a   Regez, Katharina ^a   Kaeslin, Martha ^a   Minder, Ursina ^a   Hunziker, Renate ^a   Zhydkov, Andriy ^a   Kahles, Timo ^a   Nedeltchev, Krassen ^a   Schäfer Keller, Petra ^a   Felten, Stefanie von ^f   Geest, Sabina De ^d   Perrig Chiello, Pasqualina ^g   Philippon, Anne Laure ^h   Pariente, David ^h   Bokobza, Jérome ^h   Aubry, Adeline ^h   Tommaso, Nadia De ^h   Cherubini, Ilaria ^h   Lecocq, Aline ^h   Kachetel, Kahina ^h   Virgil, Rebecca ^c   Simpson, Jo ^c   more..

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Morton Plant Hospital   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; PROADRENOMEDULLIN; PROCALCITONIN; ADRENOMEDULLIN; BIOLOGICAL MARKER; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; GLYCOPEPTIDE; PROTEIN PRECURSOR;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; EARLY INTERVENTION; EMERGENCY HEALTH SERVICE; EMERGENCY PATIENT; FEMALE; FOLLOW UP; FRANCE; GENDER; GOLD STANDARD; HELP SEEKING BEHAVIOR; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SWITZERLAND; SYMPTOM; UNITED STATES; AGED; BLOOD; CLINICAL TRIAL; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RISK; STATISTICAL MODEL;

ADRENOMEDULLIN; ADULT; AGED; BIOMARKERS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLYCOPEPTIDES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK; TRIAGE;

EID: 84945971939     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1098-z     Document Type: Article

References (44)

1. Burt CW, McCaig LF, Rechtsteiner EA. Ambulatory medical care utilization estimates for. Adv Data. 2007;2005:1-15.
2. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2002 emergency department summary. Adv Data. 2004;2002:1-34.
3. Guttmann A, Schull MJ, Vermeulen MJ, Stukel TA. Association between waiting times and short term mortality and hospital admission after departure from emergency department: population based cohort study from Ontario. Canada BMJ. 2011;342:d2983.
4. Sun BC, Hsia RY, Weiss RE, Zingmond D, Liang LJ, Han W, et al. Effect of emergency department crowding on outcomes of admitted patients. Ann Emerg Med. 2013;61:605-11.
5. Puskarich MA, Trzeciak S, Shapiro NI, Heffner AC, Kline JA, Jones AE, et al. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation. 2011;82:1289-93.
6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-96.
7. Adams Jr HP, Effron MB, Torner J, Davalos A, Frayne J, Teal P, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke. 2008;39:87-99.
8. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705-18.
9. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
10. Christ M, Grossmann F, Winter D, Bingisser R, Platz E. Modern triage in the emergency department. Dtsch Arztebl Int. 2010;107:892-8.
11. Grossmann FF, Nickel CH, Christ M, Schneider K, Spirig R, Bingisser R. Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med. 2011;57:257-64.
12. Schuetz P, Aujesky D, Muller C, Muller B. Biomarker-guided personalised emergency medicine for all - hope for another hype? Swiss Med Wkly. 2015;145:w14079.
13. Schuetz P, Marlowe RJ, Mueller B. The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review. Clin Chem Lab Med. 2015;53:521-39.
14. Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int. 2014;2014:547818.
15. Suberviola B, Castellanos-Ortega A, Ruiz Ruiz A, Lopez-Hoyos M, Santibanez M. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med. 2013;39:1945-52.
16. Courtais C, Kuster N, Dupuy AM, Folschveiller M, Jreige R, Bargnoux AS, et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Am J Emerg Med. 2013;31:215-21.
17. Bello S, Lasierra AB, Minchole E, Fandos S, Ruiz MA, Vera E, et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J. 2012;39:1144-55.
18. Albrich WC, Dusemund F, Ruegger K, Christ-Crain M, Zimmerli W, Bregenzer T, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011;11:112.
19. Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010;14:R106.
20. De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, et al. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology. 2013;80:1278-86.
21. Ostadal P, Kruger A, Zdrahalova V, Janotka M, Vondrakova D, Neuzil P, et al. Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermia. Crit Care. 2012;16:R187.
22. Potocki M, Breidthardt T, Mueller A, Reichlin T, Socrates T, Arenja N, et al. Copeptin and risk stratification in patients with acute dyspnea. Crit Care. 2010;14:R213.
23. Kruger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Am J Respir Crit Care Med. 2010;182:1426-34.
24. Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, et al. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia. Clin Chem Lab Med. 2015;53:559-66.
25. Garnacho-Montero J, Huici-Moreno MJ, Gutierrez-Pizarraya A, Lopez I, Marquez-Vacaro JA, Macher H, et al. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically Ill patients admitted with suspicion of sepsis. Crit Care. 2014;18:R116.
26. Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17:R115.
27. Hottenrott S, Schummer W. Value of procalcitonin as an outcome-parameter after cardiac arrest. Resuscitation. 2013;84:e25-6.
28. Optimizing triage and hospitalisation in adult general medical emergency patients: the TRIAGE Study. http://www.clinicaltrials.gov/ct2/show/NCT01768494. Accessed on 10 Dec 2014.
29. Schuetz P, Hausfater P, Amin D, Haubitz S, Fassler L, Grolimund E, et al. Optimizing triage and hospitalization in adult general medical emergency patients: the triage project. BMC Emerg Med. 2013;13:12.
30. Steiner D, Renetseder F, Kutz A, Faessler L, Rast AC, Felder S, et al. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future J Emerg Med 2015 Oct 9. doi: 10.1016/j.jemermed.2015.09.008.
31. Taboulet P, Moreira V, Haas L, Porcher R, Braganca A, Fontaine JP, et al. Triage with the French Emergency Nurses Classification in Hospital scale: reliability and validity. Eur J Emerg Med. 2009;16:61-7.
32. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock. 2007;28:219-26.
33. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005;51:1823-9.
34. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52:112-9.
35. Vickers AJ, Cronin AM, Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol. 2011;11:13.
36. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-72. discussion 207-112.
37. Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, et al. Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia. Swiss Med Wkly. 2011;141:w13228.
38. Suter-Widmer I, Christ-Crain M, Zimmerli W, Albrich W, Mueller B, Schuetz P, et al. Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study. BMC Pulm Med. 2012;12:21.
39. Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: "She was probably able to ambulate, but I'm not sure". JAMA. 2011;306:1782-93.
40. Albrich WC, Ruegger K, Dusemund F, Bossart R, Regez K, Schild U, et al. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly. 2011;141:w13237.
41. Albrich WC, Ruegger K, Dusemund F, Schuetz P, Arici B, Litke A, et al. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013;42:1064-75.
42. Storm-Versloot MN, Ubbink DT, Kappelhof J, Luitse JS. Comparison of an informally structured triage system, the emergency severity index, and the Manchester triage system to distinguish patient priority in the emergency department. Acad Emerg Med. 2011;18:822-9.
43. Nickler M, Ottiger M, Steuer C, Huber A, Anderson JB, Muller B, Schuetz P. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res. 2015;16:125.
44. Kutz A, Hausfater P, Oppert M, Alan M, Grolimund E, Gast C, et al. Comparison between B.R.A.H.M.S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients, and established reference methods - a prospective multinational trial. Clin Chem Lab Med 2015. doi: 10.1515/cclm-2015-0437.